CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model
- PMID: 20164592
- DOI: 10.3233/JAD-2010-1357
CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model
Abstract
CALHM1 gene coding non-synonymous SNP P86L (rs2986017) was reported to increase the risk of Alzheimer's disease (AD) in a recent study. We have investigated this genetic variant in 2470 individuals from Spain to conduct an independent replication study of the proposed SNP marker. By applying a recessive model, we observed weak evidence of an association between P86L mutation and late-onset AD (LOAD) susceptibility in our case-control study (OR =1.38 C.I. = [1.01-1.89]). Meta-analysis of available studies also supports a recessive model for CALHM1 P86L variant and provides evidence of between study heterogeneity. Importantly, we found that adjusted mean age at AD onset in P86L homozygous LOAD patients was significantly earlier that in the rest of patients (77.01 +/- 6.1 for P86L homozygous carriers versus 79.0 +/- 6.0 for the rest of patients, p=0.002). We concluded that the CALMH1 gene may contribute to AD risk in our study population. The observed genetic model (recessive) and the estimated magnitude of the effect both imply that virtually all studies performed to date were markedly underpowered to detect this effect and underscore the importance of follow up, replication, and meta-analyses of promising genetic signals.
Similar articles
-
Lack of implication for CALHM1 P86L common variation in Italian patients with early and late onset Alzheimer's disease.J Alzheimers Dis. 2010;20(1):37-41. doi: 10.3233/JAD-2010-1345. J Alzheimers Dis. 2010. PMID: 20164602
-
No association between CALHM1 and risk for Alzheimer dementia in a Belgian population.Hum Mutat. 2009 Apr;30(4):E570-4. doi: 10.1002/humu.20990. Hum Mutat. 2009. PMID: 19191332
-
Genetic association between CALHM1, 2, and 3 polymorphisms and Alzheimer's disease in a Japanese population.J Alzheimers Dis. 2010;20(2):417-21. doi: 10.3233/JAD-2010-1380. J Alzheimers Dis. 2010. PMID: 20164573
-
No association between CALHM1 polymorphism and Alzheimer's disease risk in a Hungarian population.Psychiatr Genet. 2011 Oct;21(5):249-52. doi: 10.1097/YPG.0b013e3283457bcc. Psychiatr Genet. 2011. PMID: 21378601
-
Mitochondria sense with different kinetics the calcium entering into HeLa cells through calcium channels CALHM1 and mutated P86L-CALHM1.Biochem Biophys Res Commun. 2010 Jan 1;391(1):722-6. doi: 10.1016/j.bbrc.2009.11.127. Epub 2009 Nov 26. Biochem Biophys Res Commun. 2010. PMID: 19944073
Cited by
-
Unraveling the genes implicated in Alzheimer's disease.Biomed Rep. 2017 Aug;7(2):105-114. doi: 10.3892/br.2017.927. Epub 2017 Jun 14. Biomed Rep. 2017. PMID: 28781776 Free PMC article.
-
CLHM-1 is a functionally conserved and conditionally toxic Ca2+-permeable ion channel in Caenorhabditis elegans.J Neurosci. 2013 Jul 24;33(30):12275-86. doi: 10.1523/JNEUROSCI.5919-12.2013. J Neurosci. 2013. PMID: 23884934 Free PMC article.
-
CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease.Mol Med. 2011 Sep-Oct;17(9-10):974-9. doi: 10.2119/molmed.2011.00154. Epub 2011 May 24. Mol Med. 2011. PMID: 21629967 Free PMC article.
-
Rare variants in calcium homeostasis modulator 1 (CALHM1) found in early onset Alzheimer's disease patients alter calcium homeostasis.PLoS One. 2013 Sep 17;8(9):e74203. doi: 10.1371/journal.pone.0074203. eCollection 2013. PLoS One. 2013. PMID: 24069280 Free PMC article.
-
Genetic Factors Affecting Late-Onset Alzheimer's Disease Susceptibility.Neuromolecular Med. 2016 Mar;18(1):37-49. doi: 10.1007/s12017-015-8376-4. Epub 2015 Nov 9. Neuromolecular Med. 2016. PMID: 26553058
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases